China Establishes Fast-Track Approval Process For New Flu Anti-Virals
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities have made plans to fast-track the nation's drug-approval process, but only for products aimed at treating an epidemic, beginning with the A(H1N1) swine flu. China's State FDA established a team of review experts to be ready to speed the process for those drugs without sacrificing quality issues. A spokeswoman said the new procedures are to be used for new drugs only when the public health is threatened. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.